The problem I'm seeing here in Norway is that the bar to put people on statins is way too low given the severe side-effects and likely consequences of long-term statin use, even low doses.
I think LDL is a good biomarker, just not in isolation, and especially not a "one-size fits all" metric for individual humans.
I think LDL is a good biomarker, just not in isolation, and especially not a "one-size fits all" metric for individual humans.